He currently holds the positions of Professor of Pathology at the University of Arizona College of Medicine and Chief Scientific Officer at Ventana.
[4] Grogan holds the patents for the kinetic-mode process for automated Immunohistochemistry (IHC) and “in situ” hybridization (ISH) staining techniques.
[5] Grogan has authored or co-authored more than 200 papers on lymphoma and myeloma, including contributing to a World Health Organization (WHO) publication, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue, that is part of a series on histological and genetic typing of human tumors that covers all leukemia and lymphoma types.
[2] It provides an international standard for oncologists and pathologists for use in the design of studies monitoring response to therapy and clinical outcomes.
[6] His 2019 autobiography as to Ventana is a 200-page book, Chasing the Invisible: A Doctor's Quest to Abolish the Last Unseen Cancer Cell.